Houman Khalili is a Cardiology physician affiliated with Feinstein Institute for Medical Research. OpenAlex indexes 197 publications with 4,275 citations (h-index 29); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1150 N 35th Ave Ste 605
Hollywood, FL 330215431
Telephone
954-265-7900Provider last certified this registry record 12 Dec 2024.
Clinical trials
- Comparison of Figure-Of-Eight Suture Perclose ProGlide Suture-Mediated Closure
Sponsor: Delray Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shockwave Medical, IncProgram year20258 payments
- Edwards Lifesciences CorporationProgram year20255 payments
- Abbott LaboratoriesProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.7%Statin22.7%Atorvastatin Calcium53%Rosuvastatin Calcium47%Part D≥21 patientsBeta blocker19%Carvedilol43%Metoprolol Succinate35%Labetalol Hcl22%Part D<11 patients+ 8 more classes in this area
Blood & clotting
19.9%P2Y12 inhibitor13.2%Clopidogrel77%Prasugrel Hcl23%Part D<11 patientsFactor Xa inhibitor6.7%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
4.4%SGLT2 inhibitor4.4%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
Journal of the American College of Cardiology
2023 - Echocardiographic Versus Invasive Aortic Valve Gradients in Different Clinical Scenarios
Journal of the American Society of Echocardiography
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Nicholas Chiorazzi, MD
Feinstein Institute for Medical Research
Pravin Singhal, MD
Feinstein Institute for Medical Research
Luca Giliberto, MD, PhD
Feinstein Institute for Medical Research
Albert Fenoy, MD
Feinstein Institute for Medical Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”